Andrew Reynolds is Director of PSYCHEMEDICS CORP. Currently has a direct ownership of 28,000 shares of PMD, which is worth approximately $64,959. The most recent transaction as insider was on Aug 17, 2023, when has been sold 14,000 shares (Common Stock, $.005 Par Value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28K
0% 3M change
0% 12M change
Total Value Held $64,959

Andrew Reynolds Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 17 2023
BUY
Grant, award, or other acquisition
-
14,000 Added 33.33%
28,000 Common Stock, $.005 Pa...
May 20 2022
BUY
Grant, award, or other acquisition
-
12,000 Added 46.15%
14,000 Common Stock, $.005 Pa...
Apr 05 2022
BUY
Grant, award, or other acquisition
-
2,000 Added 50.0%
2,000 Common Stock, $.005 Pa...
AR

Andrew Reynolds

Director
Acton, MA

Track Institutional and Insider Activities on PMD

Follow PSYCHEMEDICS CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PMD shares.

Notify only if

Insider Trading

Get notified when an Psychemedics Corp insider buys or sells PMD shares.

Notify only if

News

Receive news related to PSYCHEMEDICS CORP

Track Activities on PMD